Table 2. Baseline Characteristics of Proton Pump Inhibitor Users as Compared to Non-Users.
| No daily PPI (n = 55) | Daily PPI (n = 59) | P value | |
|---|---|---|---|
| Male, % (n) | 60% (33) | 40% (25) | 0.06a |
| Age, median (range) | 29 (24 - 38) | 29 (24 - 34) | 0.519b |
| BMI, median (range) | 20.72 (19.15 - 23.72) | 21.35 (19.67 - 25.39) | 0.155b |
| F508 homozygous, % (n) | 55.6 (30) | 46.6 (27) | 0.341a |
| ppFEV1, median (range) | 57% (37 - 77) | 57% (32 - 75) | 0.932b |
| Pseudomonas, % (n) | 63.6% (35) | 76.3% (45) | 0.141a |
| Number of hospitalizations, mean ± SD | 0.9 ± 1.2 | 1.4 ± 2.1 | 0.009c |
| GER, % (n) | 30.9% (17) | 96.6% (57) | < 0.001b |
| Pancreatic insufficiency, % (n) | 83.6% (46) | 77.9% (46) | 0.443a |
aPearson’s Chi-squared test (χ2). bMann-Whitney U test. cZero-inflated Poisson.